Bots Boost Liver Cancer Outcome
March 21, 2022
https://news.vumc.org/2022/03/10/bots-boost-liver-cancer-outcome/
Liver cancer, primarily hepatocellular carcinoma (HCC), is the third most common contributor to cancer-related deaths worldwide.
Early-stage HCC has a better prognosis than advanced-stage HCC and can be treated with minimally invasive surgery, including robotic-assisted and laparoscopic options. However, few studies have examined the presumably unique and discrepant short-term and long-term outcomes of robotic-assisted and laparoscopic surgeries.
Read more.
Study incorporates genetics with smoking history to identify high-risk smokers for lung cancer screening
March 9, 2021
https://news.vumc.org/2021/03/09/study-incorporates-genetics-with-smoking-history-to-identify-high-risk-smokers-for-lung-cancer-screening
A study by Vanderbilt researchers that analyzed both smoking history and genetic risk variants for lung cancer supports modifying current guidelines to include additional smokers for lung cancer screening.
Breast cancer treatment in older women
November 20, 2020
Breast-conserving surgery (BCS) plus radiotherapy is the standard-of-care for women diagnosed with early-stage breast cancer. For women over age 70, however, radiotherapy after BCS is controversial, and U.S. National Comprehensive Cancer Network clinical practice guidelines recommend that it may be omitted.
Study finds breast cancer recurrence score has different implications for men
November 19, 2020
https://news.vumc.org/2019/11/20/study-finds-breast-cancer-recurrence-score-has-different-implications-for-men/
The TAILORx study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence according to a genetic assay test. The study indicated that chemotherapy after surgery provided little advantage in overall survival for these women, so they could forgo the treatment.